Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2026 08:05 ET | Source: WW International Inc.

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)

NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it will begin offering...
April 28, 2026 16:01 ET | Source: PMGC Holdings Inc.

UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders

UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions relate
April 28, 2026 09:00 ET | Source: MyFitnessPal

MyFitnessPal Launches Comprehensive GLP-1 Support, Helping Users Stay Consistent and Build Habits Alongside Medication to Maximize Their Experience

MyFitnessPal launches free GLP-1 Support feature, combining nutrition, medication, reminders, and side effect tracking to boost results and build lasting h
April 27, 2026 16:05 ET | Source: Structure Therapeutics Inc.

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions

SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...
April 21, 2026 10:30 ET | Source: GLP Diet

GLP Diet App Launches Personalized Wellness App for GLP-1 Medication Users, Earns 2,500+ App Reviews

GLP Diet App supports GLP-1 users (Ozempic, Mounjaro) with meal plans, 5-min workouts & progress tracking. 2,700+ reviews.
April 20, 2026 16:05 ET | Source: Kailera Therapeutics, Inc.

Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Kailera Therapeutics, Inc. (Nasdaq: KLRA), an advanced clinical-stage biotechnology company, today announced the closing of its initial public offering.
April 17, 2026 09:00 ET | Source: Omada Health, Inc.

Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds

In a 12‑week study, Omada GLP‑1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controls.
April 16, 2026 19:25 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics Announces Pricing of Initial Public Offering

Kailera Therapeutics, Inc. (Nasdaq: KLRA) today announced the pricing of its initial public offering.
April 14, 2026 22:33 ET | Source: Arla Foods Ingredients

Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe

COPENHAGEN, Denmark, April 14, 2026 (GLOBE NEWSWIRE) -- Arla Foods Ingredients has developed high-protein, nutrient-dense application concepts for users of GLP-1 anti-obesity medications, which it...
April 08, 2026 04:28 ET | Source: FormBlends

FormBlends Launches the Most Comprehensive GLP-1 and Peptide Intelligence Platform on the Internet, Featuring 7,282 Provider Profiles and 100 Clinical Research Reports

San Francisco, CA, April 08, 2026 (GLOBE NEWSWIRE) -- FormBlends, a health technology platform focused on GLP-1 weight loss results and weight management provider directory listings, today announced...